Clash of faiths: A South Korean stem-cell researcher bounces back from disgrace
By The Economist,
The Economist
| 12. 01. 2005
MANY in the West agonise over the ethical questions raised by research on stem cells taken from human embryos. In South Korea, by contrast, the prevailing attitude has been _just get on with it_. Most South Koreans have reconciled themselves to the dilemmas implicit in the field, and that has created one of the most relaxed public environments on Earth for research on such cells.
So, get on with it is exactly what Hwang Woo-Suk did. Dr Hwang achieved cult status in South Korea by putting the country on the world's scientific map with his pioneering research at Seoul National University. Until a few days ago, he was also head of the newly opened World Stem Cell Hub in Seoul. Papers streamed impressively from his laboratory, and many western scientists felt he had stolen a march on them. Then an investigative television programme reported that some of the eggs used to create the embryos (or, to be more accurate, the pre-embryonic blastocysts) that provided the stem cells had themselves been provided by two of his junior researchers.
Although Dr Hwang...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...